Stable HIV-1 integrase diversity during initial HIV-1 RNA Decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir- containing salvage therapy

Virology Journal

Volumn 10, Issue , 2013, Pages

  Noguera Julian, Marc ^a   Casadellà, Maria ^a   Pou, Christian ^a   Rodríguez, Cristina ^a   Pérez Álvarez, Susana ^a   Puig, Jordi ^b   Clotet, Bonaventura ^a,b,c   Paredes, Roger ^a,b,c  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b SIDA Hospital   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Deep sequencing; Dynamics; HIV 1; Raltegravir

Indexed keywords

DARUNAVIR; DIDANOSINE; EMTRICITABINE; ENFUVIRTIDE; ETRAVIRINE; INTEGRASE; LAMIVUDINE; MARAVIROC; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RALTEGRAVIR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; VIRUS ENZYME; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CONSENSUS SEQUENCE; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; MIDDLE AGED; SALVAGE THERAPY; VIRUS INHIBITION; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION; VIRUS RESISTANCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ANTI-HIV AGENTS; FEMALE; GENETIC VARIATION; HIV INFECTIONS; HIV INTEGRASE; HIV-1; HUMANS; MALE; MIDDLE AGED; PLASMA; PYRROLIDINONES; RNA STABILITY; RNA, VIRAL; SALVAGE THERAPY; VIRUS REPLICATION;

EID: 84888997129     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-350     Document Type: Article

References (9)

1. Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients. Metzner KJ, Allers K, Rauch P, Harrer T, AIDS 2007 21 703 711 (Pubitemid 46568627)
2. Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients. Metzner KJ, et al. Clin Infect Dis 2009 48 239 247
3. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Hirsch MS, et al. Clin Infect Dis 2008 47 266 285 (Pubitemid 351920631)
4. Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy. Kearney M, et al. J Virol 2011 85 1067 1076
5. Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study. Markowitz M, et al. J Acquir Immune Defic Syndr 2007 46 125 133 (Pubitemid 47482607)
6. Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing. Armenia D, et al. J Infect Dis 2012 205 557 567
7. Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure. Codoñer FM, et al. Antiviral Res 2010 88 281 286
8. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Katoh K, Standley DM, Mol Biol Evol 2013 30 772 780
9. APE: analyses of phylogenetics and evolution in R language. Paradis E, Claude J, Strimmer K, Bioinformatics 2004 20 289 290 (Pubitemid 38195693)